Refine by
Next Generation Sequencing Articles & Analysis
145 news found
Creative Proteomics, a global leader in proteomics and bioanalytical services, has launched its state-of-the-art N-terminal Edman Degradation service, offering researchers a precise and reliable solution for protein sequence analysis. This service leverages the classic Edman Degradation method, refined with modern technology, to deliver unparalleled accuracy in determining the N-terminal ...
Next-generation sequencing (NGS) has revolutionized the field of genomics by enabling researchers to generate vast amounts of sequence data in a single experiment. ...
As the practice worked with SOPHiA GENETICS throughout the year, it experienced the benefits of utilizing the SOPHiA DDM™ Platform for its next generation sequencing (NGS) testing and today announced it will begin to validate the SOPHiA DDM™ RNAtarget Technology and the SOPHiA DDM™ for Comprehensive Genomic Profiling (CGP) ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. The poster was recently presented at the ESMO ...
Together, SOPHiA GENETICS and Boundless Bio pioneered the ecDNA Solution (ECS) algorithm to detect the presence of ecDNA using routine clinical next-generation sequencing (NGS) data. ECS is the first ecDNA clinical trial assay and was designed by SOPHiA GENETICS in alignment with FDA guidelines as an Investigational Use Only Clinical Trial Assay ...
CD Genomics, a leading provider of genomic research solutions, today announced the launch of its cutting-edge Nanopore sequencing services, marking a significant advancement in DNA and RNA analysis capabilities. This innovative technology, developed by Oxford Nanopore Technologies, is set to transform the landscape of life sciences research, offering unprecedented insights into genetic material. ...
HER2 and FOLR1 testing by immunohistochemistry (IHC) is now available for all solid tumor cancers as an add-on to the company’s xT or xR next-generation sequencing assays. ADCs are an expanding class of therapies designed to target and kill tumor cells while sparing healthy cells. ...
ByTempus
CD Genomics, a leading provider of genomic services, is proud to announce a groundbreaking advancement in microsatellite development that is set to transform the landscape of genetic research. Leveraging the power of next-generation sequencing (NGS), CD Genomics enables researchers to harness the full potential of microsatellite markers for a ...
CD Genomics, a leading provider of high-throughput sequencing services, is at the forefront of this exciting development, empowering researchers to unlock the secrets of the lncRNA world through its state-of-the-art LncRNA Sequencing platform. "The application of next-generation sequencing has revolutionized ...
CD Genomics, a leader in genomics and sequencing services, is proud to introduce MeRIP sequencing, a state-of-the-art technology that offers a comprehensive analysis of m6A locations in RNA transcripts. CD Genomics's MeRIP sequencing workflow involves immunoprecipitation of m6A-containing RNA fragments using specific antibodies, followed by ...
CD Genomics, a prominent leader in the next generation sequencing arena, proudly announce the launch of a groundbreaking 5mC/5hmC sequencing service. ...
CD Genomics, an excellent leader in genomics and bioinformatics, has unveiled a groundbreaking leap forward in TCR-Seq technology, poised to revolutionize immune repertoire profiling. With an unwavering commitment to innovation and precision, CD Genomics continues to redefine the genomics research landscape. TCR-Seq, short for T Cell Receptor Sequencing, is an instrumental tool that enables ...
CD Genomics' Viral Metagenomic Sequencing service overcomes these challenges by utilizing cutting-edge Next-Generation Sequencing (NGS) technology coupled with advanced bioinformatics analysis. ...
CD Genomics, a renowned leader in genomics and next-generation sequencing (NGS) applications, has unveiled its cutting-edge HLA typing solutions, revolutionizing immune profiling and transplantation compatibility assessment. ...
CD Genomics, a global leader in genomics solutions, has recently unveiled its highly anticipated DAP-Seq service. This cutting-edge offering promises to provide researchers worldwide with an efficient application solution for DNA affinity purification sequencing technology. With this service, the company aims to revolutionize the field of life sciences and empower researchers to unlock the ...
Key Advantages of CD Genomics’ Whole Exome Sequencing Service: Unparalleled Precision and Depth: Employs state-of-the-art next-generation sequencing (NGS) technologies and stringent quality control measures, ensuring highly accurate and reliable sequencing results. ...
Compared to traditional sequencing approaches, Iso-Seq technology offers significant advantages. ...
CD Genomics, a global leader in transcriptomics solutions, unveils its mature Nanopore Direct RNA Sequencing service that can propel transcriptomics research to new heights. ...
CD Genomics, a leading provider of transcriptomics sequencing solutions, is pleased to announce the launch of its Exosomal RNA Sequencing service. ...